Da Vinci Medical
In Stock
Inhale H2 Hydrogen Inhalation System
Have a Question?
Limited inventory pricing for the first 10 units sold!
The Inhale H2 Hydrogen Inhalation System is designed to provide a consistent and controlled fraction of inspired hydrogen (FiH₂) using an inflatable reservoir bag. The system delivers a total gas flow rate of approximately 12 L/min, ensuring that individuals with a minute ventilation at or below this threshold receive a precise FiH₂ within the selected range (0.5 - 4% H₂).
- Consistent Hydrogen Delivery with Every Inhalation
- Precise Control for Personalized Therapy
- Stable FiH₂ Despite Breathing Variability
- More Efficient Than High-Flow Systems
- Superior Safety Features
Key Features & Benefits
- The inflatable reservoir bag helps maintain consistent hydrogen delivery with each breath, reducing variability compared to other systems with direct hydrogen flow adjustments.
- The adjustable hydrogen flow rate allows for controlled delivery, accommodating different physiological conditions.
- A total flow rate of approximately ~12 L/min helps ensure a stable hydrogen concentration (FiH₂), even with variations in breathing patterns or inhalation depth.
- The system is designed to limit safety risks by providing precise hydrogen concentrations without exceeding 4% FiH₂, helping to prevent potential safety concerns such as hypoxia and flammability risks.
Specifications
Model: InhaleH2 Unit
Dimensions: 21.3" x 16.1" x 9.3"
Weight: 27 lbs
Gas + Air Output Rate: 11.6–12 L/min (constant airflow)
Hydrogen Concentration Range: Adjustable 0.1–4% (up to 483 mL/min H₂), ±3% error range
Breathing Bag Capacity: 3 L
Water Requirement: Distilled water only; Total Dissolved Solids (TDS) < 5 ppm
Estimated Runtime: Up to 75 hours per 1-liter tank
Power Requirements: 110V or 220V AC
LED Accent Lighting: Purple (can be switched off using the internal switch)
Tax and Financing
Shipping
Free Shipping within the contiguous 48 states
Warranty
3 Year Warranty
This product comes with a three-year warranty that covers workmanship and assembly quality. The warranty does not cover damage caused by misuse, improper maintenance, or the use of liquids other than distilled water.
International Customers
International customers: to ensure a seamless and personalized ordering experience, we kindly ask that you place your orders through a direct call with our team. This allows us to cater to your specific needs, including shipping preferences and any inquiries you may have about our products. We’re excited to serve you globally!
+1-888-391-5350
Therapeutic Considerations and FiH₂ Requirements
The effectiveness of hydrogen for potential therapeutic use depends on achieving adequate concentrations of H₂ in cells. Leading research suggests that an intracellular H₂ concentration of approximately 5–10 µM may be needed to observe biological effects, which is associated with an FiH₂ of at least 1%.
- FiH₂ levels below 1% may not consistently provide the necessary intracellular concentrations for therapeutic outcomes.
- FiH₂ levels in the range of 2–4% are more likely to elevate tissue H₂ concentrations within a potentially beneficial range.
- FiH₂ levels above 4% may pose safety risks, including hypoxia and flammability concerns.
Understanding FiH₂, Flow Rate Selection, and Flammability Risks
Achieving the desired FiH₂ concentration requires careful consideration of individual respiratory dynamics.
Hydrogen inhalation delivery systems that lack a controlled total flow rate may experience significant variability in FiH₂, as fluctuations in breathing rate, inhalation volume, and exhalation patterns can impact the consistency and effectiveness of hydrogen delivery.
To reach an FiH₂ concentration of 4%, a direct H₂ flow rate of 200 mL/min to several liters per minute may be necessary, depending on individual ventilation rates. Due to safety concerns, hydrogen inhalation devices exceeding 4% FiH₂ are generally prohibited in most clinical and research settings.
Our inflatable reservoir system is designed to maintain a stable FiH₂ within a controlled and safe range, optimizing delivery for therapeutic purposes while complying with safety and regulatory standards.
Regulatory and Clinical Considerations
Most hospitals, clinics, and research institutions adhere to safety guidelines that recommend hydrogen inhalation systems not exceed 4% FiH₂. This device is designed to comply with these safety standards while delivering consistent and reproducible hydrogen administration.
Applications
- Preclinical and clinical research on hydrogen therapy
- Studies on FiH₂-dependent physiological and biochemical responses
- Controlled H₂ exposure studies to minimize confounding variables related to respiratory rate and inhalation depth
This system is designed to address the practical considerations of hydrogen inhalation research while adhering to safety and regulatory guidelines.
Frequently Asked Questions
How Is Inhale H₂ Different From Competitors?
The only system designed to deliver a controlled dose of hydrogen with each breath consistently, safely, and precisely.
Precision-Tuned for the Human Body
Delivers a targeted hydrogen concentration with each breath, aligning with natural breathing patterns for optimal absorption.
More Efficient Than High-Flow Systems
Achieves therapeutic effects with just 480 mL of hydrogen per minute—compared to constant-flow machines that may require over 7 L/min to achieve similar results.
Superior Safety Profile
Engineered with safety in mind, no explosion risks, unlike high-output machines that present significant safety concerns at industrial flow levels.
Cost-Effective Performance
Designed for efficiency, offering clinical-grade benefits without the high cost or complexity associated with other hydrogen delivery systems.
Why Doesn’t the Inhale H₂ System Also Make Hydrogen-Rich Water (HRW)?
Some inhalation devices are also designed to generate hydrogen-rich water (HRW), but the hydrogen concentration in the water produced is typically lower than what is considered effective for therapeutic purposes. Research indicates that the therapeutic benefits of HRW are dependent on the dose and concentration of hydrogen; lower concentrations may not provide the desired health effects.
We have intentionally focused on hydrogen inhalation in the Inhale H₂ system, as it is specifically designed for optimal effectiveness. For therapeutic results, we suggest pairing hydrogen inhalation with high-dose hydrogen tablets, which provide a higher concentration of hydrogen per dose than what is delivered through HRW generated by combination devices.
What Does Therapeutic Dose Mean With Hydrogen Inhalation?
The therapeutic effectiveness of hydrogen is influenced by achieving an appropriate concentration of H₂ in the body. Leading research suggests that a minimum intracellular H₂ concentration of approximately 5–10 µM may be necessary for biological effects to occur. This corresponds to an FiH₂ of at least 1%.
- FiH₂ levels below 1% may not consistently achieve the concentrations needed for therapeutic effects.
- Higher FiH₂ concentrations (e.g., 2–4%) may be more effective in elevating tissue H₂ levels within the therapeutic range.
- Exceeding 4% FiH₂ may introduce safety concerns, including the potential for flammability.
Inhale H₂ is designed to provide safe and effective hydrogen inhalation by maintaining FiH₂ levels below 4%, in line with safety standards followed by hospitals, clinics, and research institutions. This approach is intended to deliver therapeutic benefits while minimizing risks such as hypoxia or flammability, and complies with regulatory and safety guidelines to ensure reliable use.
